Xeris Pharmaceuticals Inc

NASDAQ:XERS  
3.25
-0.14 (-4.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)215.53M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.47 Million
Adjusted EPS-$0.33
See more estimates
10-Day MA$3.62
50-Day MA$4.27
200-Day MA$4.83
See more pivots

Xeris Pharmaceuticals Inc Stock, NASDAQ:XERS

180 North LaSalle Street, Suite 1600, Chicago, Illinois 60601
United States of America
Phone: +1.844.445.5704
Number of Employees: 180

Description

Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.